WallStreetZenWallStreetZen

NASDAQ: REGN
Regeneron Pharmaceuticals Inc Stock Ownership - Who owns Regeneron Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Regeneron Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Arthur F. RyanDirector2026-03-027$777.46
$5.44kSell
Arthur F. RyanDirector2026-03-0220$789.28
$15.79kSell
Arthur F. RyanDirector2026-03-0220$788.96
$15.78kSell
Arthur F. RyanDirector2026-03-022$787.34
$1.57kSell
Arthur F. RyanDirector2026-03-027$786.61
$5.51kSell
Arthur F. RyanDirector2026-03-0211$785.48
$8.64kSell
Arthur F. RyanDirector2026-03-029$784.48
$7.06kSell
Arthur F. RyanDirector2026-03-0210$783.62
$7.84kSell
Arthur F. RyanDirector2026-03-022$782.62
$1.57kSell
Arthur F. RyanDirector2026-03-022$781.21
$1.56kSell

1 of 9

REGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when REGN insiders and whales buy or sell their stock.

REGN Shareholders

What type of owners hold Regeneron Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Sanofi34.54%36,518,618$27.17BInsider
Vanguard Group Inc8.58%9,075,153$6.75BInstitution
Blackrock Inc8.27%8,741,270$6.50BInstitution
State Street Corp4.41%4,660,808$3.47BInstitution
Dodge Cox4.35%4,596,358$3.42BInstitution
Jpmorgan Chase Co3.73%3,940,160$2.93BInstitution
Franklin Resources Inc2.42%2,560,004$1.90BInstitution
Geode Capital Management LLC2.38%2,519,540$1.87BInstitution
Fmr LLC2.19%2,319,566$1.73BInstitution
Nuveen LLC1.90%2,010,517$1.50BInstitution

1 of 3

REGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
REGN68.82%31.18%Net SellingNet Selling
ARGX48.47%0.00%
ALNY82.36%17.64%Net SellingNet Selling
VRTX92.81%1.52%Net SellingNet Selling
ONC2.35%32.03%Net BuyingNet Buying
View Top Biotech Stocks

Regeneron Pharmaceuticals Stock Ownership FAQ

Who owns Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals (NASDAQ: REGN) is owned by 84.41% institutional shareholders, 38.23% Regeneron Pharmaceuticals insiders, and 0.00% retail investors. Sanofi is the largest individual Regeneron Pharmaceuticals shareholder, owning 36.52M shares representing 34.54% of the company. Sanofi's Regeneron Pharmaceuticals shares are currently valued at $26.93B.

If you're new to stock investing, here's how to buy Regeneron Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.